Sec. 3201. Allowing for more flexibility with respect to medication-assisted treatment for opioid use disorders
531 words·~2 min read·
/bill/115/hr/6/eah/section-3201A research copy — for the controlling text, always check the official state or federal source. Not legal advice.
Subclause
(II)of section 303(g)(2)(B)(iii) of the Controlled Substances Act ( 21 U.S.C. 823(g)(2)(B)(iii) ) is amended to read as follows: The applicable number is— 100 if, not sooner than 1 year after the date on which the practitioner submitted the initial notification, the practitioner submits a second notification to the Secretary of the need and intent of the practitioner to treat up to 100 patients; 100 if the practitioner holds additional credentialing, as defined in section 8.2 of title 42, Code of Federal Regulations (or successor regulations); 100 if the practitioner provides medication-assisted treatment
(MAT)using covered medications (as such terms are defined in section 8.2 of title 42, Code of Federal Regulations (or successor regulations)) in a qualified practice setting (as described in section 8.615 of title 42, Code of Federal Regulations (or successor regulations)); or 275 if the practitioner meets the requirements specified in sections 8.610 through 8.655 of title 42, Code of Federal Regulations (or successor regulations). . Clause
(iii)of section 303(g)(2)(G) of the Controlled Substances Act ( 21 U.S.C. 823(g)(2)(G) ) is amended— in subclause (I), by striking or at the end; and by amending subclause
(II)to read as follows: a qualifying other practitioner, as defined in clause (iv), who is a nurse practitioner or physician assistant; or . Clause
(iii)of section 303(g)(2)(G) of the Controlled Substances Act ( 21 U.S.C. 823(g)(2)(G) ), as amended by subsection (b), is further amended by adding at the end the following: for the period beginning on October 1, 2018, and ending on October 1, 2023, a qualifying other practitioner, as defined in clause (iv), who is a clinical nurse specialist, certified registered nurse anesthetist, or certified nurse midwife. . Section 303(g)(2)(G)(iv) of the Controlled Substances Act ( 21 U.S.C. 823(g)(2)(G)(iv) ) is amended by striking nurse practitioner or physician assistant each place it appears and inserting nurse practitioner, clinical nurse specialist, certified registered nurse anesthetist, certified nurse midwife, or physician assistant . Not later than 2 years after the date of the enactment of this Act, the Secretary of Health and Human Services, in consultation with the Drug Enforcement Administration, shall submit to Congress a report that assesses the care provided by qualifying practitioners (as defined in section 303(g)(2)(G)(iii) of the Controlled Substances Act ( 21 U.S.C. 823(g)(2)(G)(iii) )) who are treating, in the case of physicians, more than 100 patients, and in the case of qualifying practitioners who are not physicians, more than 30 patients. Such report shall include recommendations on future applicable patient number levels and limits. In preparing such report, the Secretary shall study, with respect to opioid use disorder treatment— the average frequency with which qualifying practitioners see their patients; the average frequency with which patients receive counseling, including the rates by which such counseling is provided by such a qualifying practitioner directly, or by referral; the frequency of toxicology testing, including the average frequency with which random toxicology testing is administered; the average monthly patient caseload for each type of qualifying practitioner; the treatment retention rates for patients; overdose and mortality rates; and any available information regarding the diversion of drugs by patients receiving such treatment from such a qualifying practitioner.
Connectionstraces to 1
Traces to 1 document
U.S. Code
Citation graph
cites case law
Sec. 3201
Allowing for more flexibility with respect to medication-assisted treatment for opioid use disorders
Cites 1Cited by 0 across 0 sources